Latest News about NASDAQ:MIRA
Recent news which mentions NASDAQ:MIRA
MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025
September 19, 2024
Tickers
MIRA
Tags
NASDAQ:MIRA
From News Direct
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024
August 13, 2024
Tickers
MIRA
From InvestorPlace
Tickers
MIRA
From InvestorPlace
Tickers
MIRA
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>